RecruitingNot ApplicableNCT04606693

Value of Screening and Treatment of SAHS in the Management of AF Ablation Candidates

Value of Screening and Treatment of Sleep Apnea-Hypopnea Syndrome in the Management of Atrial Fibrillation Ablation Candidates


Sponsor

Hospital San Carlos, Madrid

Enrollment

50 participants

Start Date

Nov 5, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

The present prospective cohort study (not randomized) analyses the value of screening and treatment of SAHS in the management of patients with AF refractory to antiarrhythmics drugs, potentially candidates for ablation. Patients at low risk of suffering from SAHS will follow conventional management of their AF, according to the usual criteria of the Arrhythmia Unit. Patients with high or intermediate risk of SAHS, will undergo respiratory polygraphy. If the result is positive, they will be treated as standard for this syndrome and their heart rate will be monitored for 3 months. After this, the patient's arrhythmic load will be reevaluated differentiating patients into two groups, those that must be ablated from those that have improved their condition and the clinical criteria is no longer ablation but follow-up.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at whether screening and treating sleep apnea (interrupted breathing during sleep) can improve outcomes for people with an irregular heartbeat (atrial fibrillation) who are being considered for a procedure to correct their heart rhythm. **You may be eligible if...** - You have been diagnosed with paroxysmal or persistent atrial fibrillation (irregular heartbeat) - Your atrial fibrillation keeps coming back despite trying at least one anti-arrhythmia medication - You have not been previously diagnosed with sleep apnea - You are 18 or older **You may NOT be eligible if...** - You are under 18 years old - You are pregnant - You are unable to perform a home sleep breathing test - You do not own or cannot use a smartphone (needed for rhythm monitoring) - You cannot attend follow-up visits at the study center for at least one year Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTreatment of SAHS

Patients diagnosed with SAHS will be treated in the Pneumology Service according to usual practice (dietary hygienic measures, CPAP, etc.).


Locations(1)

Hospital Clínico San Carlos

Madrid, Madrid, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04606693


Related Trials